Latest news with #PHKL
Malaysian Reserve
6 hours ago
- Health
- Malaysian Reserve
Pantai Hospital Kuala Lumpur Advances Adult Congenital Heart Care with First Minimally Invasive PDA Device Closure
KUALA LUMPUR, Malaysia, June 6, 2025 /PRNewswire/ — Pantai Hospital Kuala Lumpur (PHKL) marked a significant milestone in cardiovascular care with the successful transcatheter device occlusion of a patent ductus arteriosus (PDA) in an adult patient with congenital heart disease — a first for the hospital's Interventional Cardiology Laboratory (ICL). The patient, who was initially referred for open-heart surgery involving PDA ligation and ventricular septal defect (VSD) closure, was carefully evaluated by PHKL's multidisciplinary cardiac team. A detailed transoesophageal echocardiogram (TOE) revealed a single tiny VSD that did not require immediate surgical repair, allowing the team to opt for a less invasive, catheter-based approach. 'This case is a testament to multidisciplinary, patient-centred approach,' said Dr Siti Laura, Consultant Paediatric Cardiothoracic Surgeon at PHKL. 'By opting for a minimally invasive PDA device occlusion, we were able to offer the patient a faster recovery, smaller incision, and significantly reduced scarring.' This successful procedure highlights PHKL's expanding capabilities in adult congenital heart care, a specialised and growing field that requires collaborative planning and tailored interventions. It also reflects the hospital's commitment to delivering innovative, minimally invasive solutions for structural heart conditions in adults — a group often underrepresented in congenital cardiac care Our ability to perform such procedures reflects the hospital's continuous investment in advanced cardiac technology and our commitment to improving outcomes for patients with congenital heart disease,' Dr Siti Laura added. 'We will continue to monitor the patient's condition closely — particularly her VSD — to ensure optimal long-term care. PHKL reinforces its position as a tertiary referral centre and a growing centre of excellence for adult congenital heart disease management in Malaysia. For more information about Paediatric and Congenital Cardiothoracic Services at PHKL, please visit: -END- *** Dr Siti Laura Mazalan, Consultant Paediatric and Congenital Cardiothoracic Surgeon MBBS (University of Malaya, Malaysia), MMed Surg (University Kebangsaan Malaysia, Malaysia), Fellowship in Paediatric Cardiac Surgery (Birmingham Children Hospital, United Kingdom) Dr. Siti Laura is a highly accomplished Paediatric Cardiothoracic Surgeon deeply committed to serving vulnerable in Malaysia. Her medical journey commenced with an MBBS from the University of Malaya in 1998, followed by a Master of Medicine (Surgery) from Universiti Kebangsaan Malaysia in 2004. Beginning her career at Institute Jantung Negara in 2004, she devoted 14 years to the institution as a Consultant Cardiothoracic Surgeon. Motivated by her dedication to enhancing healthcare, she pursued a transformative one-year Fellowship in Paediatric Cardiac Surgery at Birmingham Children's Hospital in 2010. In 2020, Dr. Siti Laura joined Serdang Hospital, where she played a pivotal role in establishing the Paediatric Cardiothoracic service, catering to underprivileged children with congenital heart diseases in the nation. She subsequently became a Consultant Paediatric Cardiothoracic Surgeon at Pantai Hospital Kuala Lumpur. Dr Siti Laura's area of interest includes Neonatal and Paediatric Cardiothoracic Surgery, Adult Congenital Cardiac Surgery, Single Ventricle Heart Surgery, ECMO support (Extracorporeal membrane oxygenation), Slide Tracheoplasty Surgery in neonates and paediatric patients and Cardiac Homograft Banking. Dr Siti Laura's expertise and unwavering dedication continue to make a profound impact on the lives of her patients and the healthcare community. *** About Pantai Hospital Kuala Lumpur For five decades, Pantai Hospital Kuala Lumpur has been the heartbeat of Kuala Lumpur, steadfastly delivering exceptional care to patients from all walks of life. Since its inception in 1974 with just 68 beds and 20 medical specialists, the hospital has grown into a healthcare icon today with 507 beds, over 200 consultants and counting. Our pursuit of quality healthcare, clinical excellence, and cutting-edge technology is underscored by our service quality and dedication towards clinical research. This has earned us accreditations from the Malaysian Society for Quality in Health (MSQH) and the Joint Commission International (JCI). Additionally, we hold certification as a Baby-Friendly Hospital and is a preferred hospital in Malaysia by the World Health Organization (WHO). As we celebrate our 50th anniversary, Pantai Hospital Kuala Lumpur looks to the future, unwaveringly committed to continuing its legacy of excellence with world-class healthcare services and innovative treatments for generations to come. Learn more at For more information, please contact:Callie Phin, Pantai Hospital Kuala LumpurEmail: Tel No.: 014-686 7066 For media enquiry:Natasha Loo, PR Lab ConsultancyEmail: tasha@ Tel No.: 010-231 0110 Lim Joe Ee, PR Lab ConsultancyEmail: Tel No.: 012-635 9839 Ally Chai, PR Lab ConsultancyEmail: ally@ Tel No.: 016-232 7625
Yahoo
7 hours ago
- Health
- Yahoo
Pantai Hospital Kuala Lumpur Advances Adult Congenital Heart Care with First Minimally Invasive PDA Device Closure
KUALA LUMPUR, Malaysia, June 6, 2025 /PRNewswire/ -- Pantai Hospital Kuala Lumpur (PHKL) marked a significant milestone in cardiovascular care with the successful transcatheter device occlusion of a patent ductus arteriosus (PDA) in an adult patient with congenital heart disease — a first for the hospital's Interventional Cardiology Laboratory (ICL). The patient, who was initially referred for open-heart surgery involving PDA ligation and ventricular septal defect (VSD) closure, was carefully evaluated by PHKL's multidisciplinary cardiac team. A detailed transoesophageal echocardiogram (TOE) revealed a single tiny VSD that did not require immediate surgical repair, allowing the team to opt for a less invasive, catheter-based approach. "This case is a testament to multidisciplinary, patient-centred approach," said Dr Siti Laura, Consultant Paediatric Cardiothoracic Surgeon at PHKL. "By opting for a minimally invasive PDA device occlusion, we were able to offer the patient a faster recovery, smaller incision, and significantly reduced scarring." This successful procedure highlights PHKL's expanding capabilities in adult congenital heart care, a specialised and growing field that requires collaborative planning and tailored interventions. It also reflects the hospital's commitment to delivering innovative, minimally invasive solutions for structural heart conditions in adults — a group often underrepresented in congenital cardiac care Our ability to perform such procedures reflects the hospital's continuous investment in advanced cardiac technology and our commitment to improving outcomes for patients with congenital heart disease," Dr Siti Laura added. "We will continue to monitor the patient's condition closely — particularly her VSD — to ensure optimal long-term care. PHKL reinforces its position as a tertiary referral centre and a growing centre of excellence for adult congenital heart disease management in Malaysia. For more information about Paediatric and Congenital Cardiothoracic Services at PHKL, please visit: -END- *** Dr Siti Laura Mazalan, Consultant Paediatric and Congenital Cardiothoracic Surgeon MBBS (University of Malaya, Malaysia), MMed Surg (University Kebangsaan Malaysia, Malaysia), Fellowship in Paediatric Cardiac Surgery (Birmingham Children Hospital, United Kingdom) Dr. Siti Laura is a highly accomplished Paediatric Cardiothoracic Surgeon deeply committed to serving vulnerable in Malaysia. Her medical journey commenced with an MBBS from the University of Malaya in 1998, followed by a Master of Medicine (Surgery) from Universiti Kebangsaan Malaysia in 2004. Beginning her career at Institute Jantung Negara in 2004, she devoted 14 years to the institution as a Consultant Cardiothoracic Surgeon. Motivated by her dedication to enhancing healthcare, she pursued a transformative one-year Fellowship in Paediatric Cardiac Surgery at Birmingham Children's Hospital in 2010. In 2020, Dr. Siti Laura joined Serdang Hospital, where she played a pivotal role in establishing the Paediatric Cardiothoracic service, catering to underprivileged children with congenital heart diseases in the nation. She subsequently became a Consultant Paediatric Cardiothoracic Surgeon at Pantai Hospital Kuala Lumpur. Dr Siti Laura's area of interest includes Neonatal and Paediatric Cardiothoracic Surgery, Adult Congenital Cardiac Surgery, Single Ventricle Heart Surgery, ECMO support (Extracorporeal membrane oxygenation), Slide Tracheoplasty Surgery in neonates and paediatric patients and Cardiac Homograft Banking. Dr Siti Laura's expertise and unwavering dedication continue to make a profound impact on the lives of her patients and the healthcare community. *** About Pantai Hospital Kuala Lumpur For five decades, Pantai Hospital Kuala Lumpur has been the heartbeat of Kuala Lumpur, steadfastly delivering exceptional care to patients from all walks of life. Since its inception in 1974 with just 68 beds and 20 medical specialists, the hospital has grown into a healthcare icon today with 507 beds, over 200 consultants and counting. Our pursuit of quality healthcare, clinical excellence, and cutting-edge technology is underscored by our service quality and dedication towards clinical research. This has earned us accreditations from the Malaysian Society for Quality in Health (MSQH) and the Joint Commission International (JCI). Additionally, we hold certification as a Baby-Friendly Hospital and is a preferred hospital in Malaysia by the World Health Organization (WHO). As we celebrate our 50th anniversary, Pantai Hospital Kuala Lumpur looks to the future, unwaveringly committed to continuing its legacy of excellence with world-class healthcare services and innovative treatments for generations to come. Learn more at For more information, please contact:Callie Phin, Pantai Hospital Kuala LumpurEmail: Tel No.: 014-686 7066 For media enquiry:Natasha Loo, PR Lab ConsultancyEmail: tasha@ Tel No.: 010-231 0110 Lim Joe Ee, PR Lab ConsultancyEmail: Tel No.: 012-635 9839 Ally Chai, PR Lab ConsultancyEmail: ally@ Tel No.: 016-232 7625 View original content to download multimedia: SOURCE Pantai Hospital Kuala Lumpur
Malaysian Reserve
23-05-2025
- Health
- Malaysian Reserve
ADVANCING ENDOSCOPIC EXCELLENCE
Pantai Hospital Kuala Lumpur Reaches 50 POEM Cases, Leading the Way in Minimally Invasive, Incisionless Treatment KUALA LUMPUR, Malaysia, May 23, 2025 /PRNewswire/ — Pantai Hospital Kuala Lumpur (PHKL) proudly celebrates a major milestone in its endoscopic journey, having successfully performed 50 Peroral Endoscopic Myotomy (POEM) procedures since the service was introduced in 2020. This achievement highlights the hospital's growing leadership in advanced, minimally invasive gastrointestinal treatments. The POEM procedures are led by Dr. Lau Peng Choong, Consultant Upper Gastrointestinal (GI) Surgeon at PHKL. POEM is a cutting-edge, incisionless procedure used to treat achalasia, a rare disorder that affects the ability of the oesophagus to move food into the stomach. 'We're proud to reach this milestone of 50 POEM cases,' said Dr. Lau. 'This treatment has significantly improved the quality of life for patients with achalasia—a condition that's often misdiagnosed as acid reflux or anxiety. With POEM, we can now offer an effective, minimally invasive solution with quicker recovery and less discomfort.' Unlike traditional or even laparoscopic surgeries, POEM is performed entirely using an endoscope passed through the mouth. The technique involves cutting the muscles at the lower end of the oesophagus to allow smoother passage of food, offering faster recovery times, less pain, and lower complication risks. Expanding the Scope of Endoscopic Expertise In addition to POEM, Dr. Lau Peng Choong, Consultant Upper GI Surgeon, and Dr. Gew Lai Teck, Consultant Gastroenterologist & Hepatologist, have successfully performed Endoscopic Submucosal Dissection (ESD) for close to 20 patients with Stage 1 gastrointestinal cancers, eliminating the need for minimally invasive or open surgery. ESD is a highly precise procedure that allows for the removal of complex growths—such as early cancers or large polyps—from the gastrointestinal tract without external incisions. Both specialists are extensively trained in advanced endoscopic interventions, and their expertise is supported by a dedicated multidisciplinary team, ensuring that patients receive seamless, collaborative, and comprehensive care. 'With the recent introduction of Endoscopic Sleeve Gastroplasty (ESG), we're further broadening our scope of minimally invasive treatment options,' shared Dr. Lau. 'From cancer treatment to obesity management and digestive disorders, we're committed to helping patients heal faster, feel better, and return to daily life sooner.' PHKL is now offering ESG procedures at an introductory rate of RM25,000, making it an accessible solution for patients considering effective weight management treatments. The procedure is performed by Dr Lau Peng Choong, Consultant Upper Gastrointestinal Surgeon, and Dr Gew Lai Teck, Consultant Gastroenterologist—both trained and experienced in advanced endoscopic techniques. For further information on the technologies used in these procedures: Learn more about Endoscopic Submucosal Dissection (ESD): Olympus Medical Solutions – ESD Overview Learn more about Endoscopic Sleeve Gastroplasty (ESG): Boston Scientific – ESG Overview These advanced instruments are provided by PHKL's official vendors—Olympus Medical Solutions and Boston Scientific. For more information on Pantai Hospital Kuala Lumpur, visit About Pantai Hospital Kuala LumpurFor five decades, Pantai Hospital Kuala Lumpur has been the heartbeat of Kuala Lumpur, steadfastly delivering exceptional care to patients from all walks of life. Since its inception in 1974 with just 68 beds and 20 medical specialists, the hospital has grown into a healthcare icon today with 507 beds, over 200 consultants and counting. Our pursuit of quality healthcare, clinical excellence, and cutting-edge technology is underscored by our service quality and dedication towards clinical research. This has earned us accreditations from the Malaysian Society for Quality in Health (MSQH) and the Joint Commission International (JCI). Additionally, we hold certification as a Baby-Friendly Hospital and is a preferred hospital in Malaysia by the World Health Organization (WHO). As we celebrate our 50th anniversary, Pantai Hospital Kuala Lumpur looks to the future, unwaveringly committed to continuing its legacy of excellence with world-class healthcare services and innovative treatments for generations to come. Learn more at
Yahoo
16-05-2025
- Health
- Yahoo
PHKL Showcases Robotic Precision in Orthopaedic Care
KUALA LUMPUR, Malaysia, May 16, 2025 /PRNewswire/ -- Pantai Hospital Kuala Lumpur (PHKL) recently hosted its first-ever Ortho Experience Day, offering a rare, hands-on look at the hospital's cutting-edge MAKO Robotic Surgery System—a transformative tool in joint replacement procedures. Guests were invited to operate the robotic arm on a surgical dummy, experiencing first-hand how robotic-assisted technology improves surgical precision, implant placement, and recovery time. PHKL's orthopaedic specialists were also on hand to discuss the evolving landscape of bone, joint, and sports injury treatments. Robotic-assisted joint replacement surgery offers a range of benefits for patients, including: Greater surgical precision and implant accuracy Personalised surgical planning based on each patient's anatomy Reduced soft tissue damage and post-operative pain Faster recovery times and shorter hospital stays Improved long-term joint function and implant lifespan The hands-on experience reflects PHKL's long-term commitment to integrating state-of-the-art technologies not only in patient care, but also in the training and upskilling of medical professionals, ensuring patients receive the most advanced and personalised treatments available. With joint conditions such as osteoarthritis affecting more Malaysians each year, PHKL is proud to highlight its ongoing commitment to advanced technologies that support faster recovery, improved outcomes, and personalised orthopaedic care. For more information on Pantai Hospital Kuala Lumpur's services in Robotic Surgery, visit About Pantai Hospital Kuala Lumpur For five decades, Pantai Hospital Kuala Lumpur has been the heartbeat of Kuala Lumpur, steadfastly delivering exceptional care to patients from all walks of life. Since its inception in 1974 with just 68 beds and 20 medical specialists, the hospital has grown into a healthcare icon today with 507 beds, over 200 consultants and counting. Our pursuit of quality healthcare, clinical excellence, and cutting-edge technology is underscored by our service quality and dedication towards clinical research. This has earned us accreditations from the Malaysian Society for Quality in Health (MSQH) and the Joint Commission International (JCI). Additionally, we hold certification as a Baby-Friendly Hospital and is a preferred hospital in Malaysia by the World Health Organization (WHO). As we celebrate our 50th anniversary, Pantai Hospital Kuala Lumpur looks to the future, unwaveringly committed to continuing its legacy of excellence with world-class healthcare services and innovative treatments for generations to come. Learn more at For more information, please contact:Callie Phin, Pantai Hospital Kuala LumpurEmail: No.: 014-686 7066 View original content to download multimedia: SOURCE Pantai Hospital Kuala Lumpur
The Star
07-05-2025
- Business
- The Star
Pavilion-REIT gets nod to acquire hotels for RM480mil
The move is expected to enhance Pavilion-REIT's long-term performance and reinforce its presence in Bukit Bintang. PETALING JAYA: Pavilion Real Estate Investment Trust (Pavilion-REIT) has received unitholder approval to acquire Banyan Tree Kuala Lumpur (BTKL) and Pavilion Hotel Kuala Lumpur (PHKL) for RM480mil, a move expected to enhance its long-term performance and reinforce its presence in Bukit Bintang. Pavilion-REIT, in a statement, said the resolutions passed at the unitholders' meeting will allow MTrustee Bhd, on behalf of the REIT, to proceed with the acquisition of the properties from Lumayan Indah Sdn Bhd and Harmoni Perkasa Sdn Bhd. 'We are pleased with the strong support from our unitholders. These hotels are highly synergistic with Pavilion Kuala Lumpur Mall and Elite Pavilion Mall, allowing for an elevated visitor and hotel guest experience,' Pavilion REIT Management Sdn Bhd chief executive officer Datuk Philip Ho said. The two properties are 5-star hotels operated and managed by Banyan Tree Hotels & Resorts Pte Ltd, and achieved occupancy rates of 82.1% (BTKL) and 81.5% (PHKL) for the financial year ended Dec 31, 2024. Pavilion-REIT said the acquisition will be funded through a combination of debt and or equity, including the issuance of up to 172.4 million new units to the vendors and/or their nominees, and a private placement of up to 386 million new units to raise between RM264mil and RM552mil. The hotels will be leased to Harmoni Perkasa for an initial 10-year term, with renewal options extending up to 20 years. The lease guarantees a fixed annual rental of RM33.5mil for the first five years, offering a gross yield of about 7%.
